BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34861885)

  • 1. ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism.
    Khare S; Kim LC; Lobel G; Doulias PT; Ischiropoulos H; Nissim I; Keith B; Simon MC
    Cancer Metab; 2021 Dec; 9(1):40. PubMed ID: 34861885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
    Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis.
    Rabinovich S; Adler L; Yizhak K; Sarver A; Silberman A; Agron S; Stettner N; Sun Q; Brandis A; Helbling D; Korman S; Itzkovitz S; Dimmock D; Ulitsky I; Nagamani SC; Ruppin E; Erez A
    Nature; 2015 Nov; 527(7578):379-383. PubMed ID: 26560030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis.
    Sun W; Kou H; Fang Y; Xu F; Xu Z; Wang X; Yin R; Zhang Q; Jiang Q; Xu Y
    Oncogene; 2024 Jan; 43(3):216-223. PubMed ID: 38049565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression.
    Sciacovelli M; Dugourd A; Jimenez LV; Yang M; Nikitopoulou E; Costa ASH; Tronci L; Caraffini V; Rodrigues P; Schmidt C; Ryan DG; Young T; Zecchini VR; Rossi SH; Massie C; Lohoff C; Masid M; Hatzimanikatis V; Kuppe C; Von Kriegsheim A; Kramann R; Gnanapragasam V; Warren AY; Stewart GD; Erez A; Vanharanta S; Saez-Rodriguez J; Frezza C
    Nat Commun; 2022 Dec; 13(1):7830. PubMed ID: 36539415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
    Jęśko H; Lukiw WJ; Wilkaniec A; Cieślik M; Gąssowska-Dobrowolska M; Murawska E; Hilgier W; Adamczyk A
    J Alzheimers Dis; 2018; 62(1):279-291. PubMed ID: 29439324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1.
    Qualls JE; Subramanian C; Rafi W; Smith AM; Balouzian L; DeFreitas AA; Shirey KA; Reutterer B; Kernbauer E; Stockinger S; Decker T; Miyairi I; Vogel SN; Salgame P; Rock CO; Murray PJ
    Cell Host Microbe; 2012 Sep; 12(3):313-23. PubMed ID: 22980328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
    Huang Z; Wang TS; Zhao YC; Zuo RJ; Deng WB; Chi YJ; Yang ZM
    Mol Cell Endocrinol; 2014 May; 388(1-2):20-31. PubMed ID: 24556046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
    Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
    Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.
    Zou Z; Hu X; Luo T; Ming Z; Chen X; Xia L; Luo W; Li J; Xu N; Chen L; Cao D; Wen M; Kong F; Peng K; Xie Y; Li X; Ma D; Yang C; Chen C; Yi W; Liu O; Liu S; Luo J; Luo Z
    Nat Commun; 2021 Apr; 12(1):2263. PubMed ID: 33859183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.
    Erez A; Nagamani SC; Lee B
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):45-53. PubMed ID: 21312326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.
    Huang HL; Hsu HP; Shieh SC; Chang YS; Chen WC; Cho CY; Teng CF; Su IJ; Hung WC; Lai MD
    Mol Cancer Ther; 2013 Nov; 12(11):2505-16. PubMed ID: 23979921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.
    Ochocki JD; Khare S; Hess M; Ackerman D; Qiu B; Daisak JI; Worth AJ; Lin N; Lee P; Xie H; Li B; Wubbenhorst B; Maguire TG; Nathanson KL; Alwine JC; Blair IA; Nissim I; Keith B; Simon MC
    Cell Metab; 2018 Jun; 27(6):1263-1280.e6. PubMed ID: 29754953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of argininosuccinate synthase and argininosuccinate lyase from the liver of the African lungfish Protopterus annectens, and their mRNA expression levels in the liver, kidney, brain and skeletal muscle during aestivation.
    Chng YR; Ong JL; Ching B; Chen XL; Wong WP; Chew SF; Ip YK
    J Comp Physiol B; 2014 Oct; 184(7):835-53. PubMed ID: 25034132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.
    Herrera Sanchez MB; Previdi S; Bruno S; Fonsato V; Deregibus MC; Kholia S; Petrillo S; Tolosano E; Critelli R; Spada M; Romagnoli R; Salizzoni M; Tetta C; Camussi G
    Stem Cell Res Ther; 2017 Jul; 8(1):176. PubMed ID: 28750687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
    Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
    Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide is required for lung alveolarization revealed by deficiency of argininosuccinate lyase.
    Jin Z; Jiang MM; Lee B
    Hum Mol Genet; 2023 Dec; 33(1):33-37. PubMed ID: 37738569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer.
    Silberman A; Goldman O; Boukobza Assayag O; Jacob A; Rabinovich S; Adler L; Lee JS; Keshet R; Sarver A; Frug J; Stettner N; Galai S; Persi E; Halpern KB; Zaltsman-Amir Y; Pode-Shakked B; Eilam R; Anikster Y; Nagamani SCS; Ulitsky I; Ruppin E; Erez A
    Cancer Res; 2019 Feb; 79(3):518-533. PubMed ID: 30573518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism.
    Fu Y; Liu S; Rodrigues RM; Han Y; Guo C; Zhu Z; He Y; Mackowiak B; Feng D; Gao B; Zeng S; Shen H
    Int J Biol Sci; 2022; 18(11):4341-4356. PubMed ID: 35864952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.